Quick Answer
Ernexa Therapeutics Inc. reported Shares Outstanding of 7.85 million shares for fiscal year 2025.
Ernexa Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 7.85M | +129.2% |
| 2024 | 3.43M | -93.3% |
| 2024 | 51.39M | +849.8% |
| 2023 | 5.41M | +5.5% |
| 2022 | 5.13M | +97.1% |
| 2021 | 2.60M | — |
| 2020 | 0 | -100.0% |
| 2019 | 2.90M | +0.9% |
| 2018 | 2.88M | +14.0% |
| 2017 | 2.52M | +11.5% |
| 2016 | 2.26M | -97.6% |
| 2016 | 92.44M | +4899.4% |
| 2015 | 1.85M | -98.0% |
| 2014 | 92.37M | +17.4% |
| 2013 | 78.65M | +10.6% |
| 2012 | 71.12M | +116634.8% |
| 2011 | 60,927 | +0.3% |
| 2010 | 60,751 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 7.85M | +45.1% | +4.9% |
| June 30, 2025 | 7.48M | +38.3% | -85.7% |
| March 31, 2025 | 52.25M | +865.8% | +1425.1% |
| December 31, 2024 | 3.43M | -36.7% | -36.7% |
| September 30, 2024 | 5.41M | +0.0% | +0.0% |
| June 30, 2024 | 5.41M | +0.0% | +0.0% |
| March 31, 2024 | 5.41M | +5.5% | +0.0% |
| December 31, 2023 | 5.41M | +5.5% | +0.0% |
- Ernexa Therapeutics Inc. showed an increase of +129.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Ernexa Therapeutics Inc.’s shares outstanding has grown by 12828.2% (from 60.8 thousand shares to 7.85 million shares).
- The most recent figure is from Ernexa Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: